The Smart Inhalers Market is emerging as an important segment of connected healthcare, combining inhalation therapy with digital monitoring, sensors, Bluetooth connectivity, and mobile applications. Smart inhalers help patients and healthcare professionals monitor medication usage, adherence, dosage timing, and treatment patterns. According to Market Research Future, the global market was valued at USD 3.21 billion in 2025 and is projected to reach USD 11.40 billion by 2035, registering a CAGR of 13.5%.

One of the major factors supporting market expansion is the increasing burden of chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Patients with these conditions often require long-term inhaled medications, making consistent adherence essential for effective disease management. Smart inhalers provide reminders and digital records that can help patients follow prescribed treatment schedules more effectively.

Technology is also changing the way inhaler therapy is delivered. Sensor-based systems can capture information related to inhaler activation, dosage timing, and usage frequency. When connected to smartphones or cloud-based platforms, this information can be shared with healthcare professionals, allowing them to identify adherence problems and make better-informed treatment decisions.

The product segment is led by metered dose inhalers, which accounted for 68.7% of the market in 2025. Their established clinical use and widespread manufacturing infrastructure provide an important foundation for smart technology integration. Dry powder inhalers are also gaining attention because their breath-actuated operation can simplify medication delivery while supporting sustainability goals.

Artificial intelligence is expected to create additional opportunities. AI-enabled applications can analyze inhaler-use patterns alongside environmental information, symptom data, and other variables to identify potential risks. Such capabilities could support earlier intervention and personalized respiratory care.

Overall, smart inhalers are shifting respiratory treatment from conventional medication delivery toward connected and data-driven disease management. Continued improvements in sensors, mobile applications, interoperability, reimbursement, and digital healthcare infrastructure are expected to support adoption across hospitals, homecare settings, and pharmaceutical programs.